Prognostic value of FDG uptake in early stage non-small cell lung cancer.
暂无分享,去创建一个
Max Lonneux | François-Xavier Hanin | P. Noirhomme | A. Poncelet | M. Lonneux | Philippe Noirhomme | F. Hanin | Julien Cornet | Corinne Coulon | Julien Distexhe | Alain J Poncelet | Julien Cornet | Julien Distexhe | C. Coulon
[1] W. Travis,et al. The new World Health Organization classification of lung tumours , 2001, European Respiratory Journal.
[2] H. Dittmann,et al. Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[3] Ursula Nestle,et al. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[4] T. Stijnen,et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. , 2005, The Annals of thoracic surgery.
[5] Matthias Reimold,et al. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Joos V Lebesque,et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. , 2005, European journal of cancer.
[7] R. Rami-Porta,et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] T. Naruke,et al. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma , 2006, Cancer.
[9] M. Defrise,et al. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction , 1999, European Journal of Nuclear Medicine.
[10] D. Kleinbaum,et al. Survival Analysis: A Self-Learning Text. , 1996 .
[11] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[12] H. Dittmann,et al. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? , 2006, European journal of nuclear medicine and molecular imaging.
[13] Martin Utley,et al. FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. , 2007, Lung cancer.
[14] R. Cerfolio,et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. , 2005, The Journal of thoracic and cardiovascular surgery.
[15] T. Naruke,et al. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma , 2006, Cancer.
[16] Yukiko Arisaka,et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Eric J. W. Visser,et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[18] P. Hermanek,et al. The pathologist and the residual tumor (R) classification. , 1994, Pathology, research and practice.
[19] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[20] F. Shepherd,et al. Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review. , 2006, Critical reviews in oncology/hematology.
[21] J. Mountz,et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. , 2003, The Annals of thoracic surgery.
[22] S. Larson,et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Rupert G. Miller,et al. Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.
[24] R. Kelly,et al. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. , 2004, Chest.